Endocrine Disease

6.14
Endocrine Disease

Diabetes Mellitus (DM) Type II

  • DM Type I covered in pediatrics on page 232
  • Etiology/Risk Factors
    • Genetics
    • Lifestyle/diet
  • Pathophysiology
    • Hyperglycemia
    • ↓ Insulin synthesis relative to increased tissue resistance (Figure 6.34)
    • Frequent comorbidities = metabolic syndrome
      • HTN
      • Dyslipidemia
      • Central obesity
    • Peripheral neuropathy
      • Distal
      • Symmetric
      • Often in stocking‐glove distribution
    • Autonomic neuropathy
      • Hypotension
      • Orthostatic hypotension
      • Impaired vasoconstriction
      • Exercise intolerance
      • Resting tachycardia
      • Silent myocardial ischemia
      • Intraoperative cardiovascular instability
    • ↓ Immune function
    • Polyuria
    • ↑ Risk of coronary artery disease
    • ↑ Risk of cerebrovascular disease
    • Nephropathy
    • Retinopathy
  • Treatment
    • Lifestyle/diet modifications
    • Hypoglycemic agents
      • Biguanides (metformin)
      • Sulfonylureas
      • Meglitinides
      • TZDs
      • GLP‐1s
      • DPP‐4s
      • α‐Glucosidase inhibitors
      • SGLT2
      • Insulin
    • Bariatric surgery
  • Primary Concerns
    • Perioperative glucose levels
    • Difficult airway
      • Glycosylation of cervical vertebrae and/or body habitus may limit neck extension
    • Atherosclerosis
      • ↑ Risk of coronary artery disease
      • ↑ Risk of CVA
      • Nephropathy
    • Autonomic neuropathy
      • Gastroparesis
      • ↑ Heart rate
  • Evaluation
    • Consult endocrinologist
    • Blood glucose
    • HbA1c
      • Generally A1C ≤ 7% is target of glycemic control
    • History
      • Hypoglycemic episodes
        • Frequency
        • Whether patient is aware
        • At what blood glucose level
    • Medications
      • Exogenous insulin usage
    • Consider BMP
    • Evaluate for any sensory defects
    • Evaluate autonomic neuropathy
      • Check heart rate variability with deep breathing
      • Presence of postural hypotension
    • Evaluate for prayer sign
      • If present, increased risk of difficult airway due to decreased joint mobility [110]
  • Anesthesia Management
    • Oral medications to continue and discontinue covered on pages 99–102
    • GLP‐1 agonists markedly suppress gastric emptying and increase risk of aspiration
    • Preoperative blood glucose
      • Adjust if needed
    • No contraindications to certain anesthetic induction or maintenance agents
    • Relative contraindication to dexamethasone as may increase blood glucose postoperatively [111, 112]
    • Consider rapid sequence induction if intubating
    • Check blood glucose levels at least hourly
    • Ideal to maintain blood glucose between 140 and 180 mg/dl [113]
    • 1800 rule to calculate approximate blood glucose drop from rapid‐acting insulin
      • Example: If they take 45 units of regular/fast acting a day, one unit should drop BG by ~40 mg/dl
        • 1800/45 = 40
    • 1 g dextrose raises BG by ~4 mg/dl
    • Stress of surgery will increase blood glucose
    • Check blood glucose prior to discharge
Two diagrams of diabetes types: Type 1 diabetes represents insulin production, while Type 2 diabetes represents insulin resistance.

Figure 6.34

Hyperthyroidism

  • Etiology/Risk Factors

Stay updated, free dental videos. Join our Telegram channel

Oct 16, 2024 | Posted by in Oral and Maxillofacial Surgery | Comments Off on Endocrine Disease

VIDEdental - Online dental courses

Get VIDEdental app for watching clinical videos